Related Experiment Video
Updated: Feb 27, 2026
28:13
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
34.2K
Dealing With the Left Atrial Appendage for Stroke Prevention: Devices and Decision-Making
Karen P Phillips1, Vince Paul2
1HeartCare Partners, GenesisCare, Greenslopes Private Hospital, Greenslopes, Brisbane, Qld, Australia.
Heart, Lung & Circulation
|June 28, 2017
Summary
Left atrial appendage (LAA) device occlusion is a proven stroke prevention strategy for atrial fibrillation (AF) patients. This therapy offers an alternative to anticoagulation, reducing bleeding risks and improving cardiovascular outcomes.
Area of Science:
- Cardiology
- Medical Devices
- Stroke Prevention
Background:
- Atrial fibrillation (AF) is a leading cause of stroke.
- Long-term anticoagulation is standard but carries bleeding risks.
- Left atrial appendage (LAA) occlusion offers an alternative stroke prevention method.
Purpose of the Study:
- To review the evolution of LAA device occlusion.
- To summarize current knowledge and clinical practice of LAA occlusion.
- To discuss risks and benefits for informed decision-making.
Main Methods:
- Literature review of LAA occlusion therapy.
- Analysis of current clinical evidence and practice.
- Synthesis of data on efficacy and safety.
Main Results:
- LAA device occlusion is effective for long-term thromboembolic stroke prevention in non-rheumatic AF.
- It serves as a viable alternative to anticoagulation, mitigating bleeding risks.
- The therapy shows potential for improved cardiovascular mortality.
Conclusions:
- LAA occlusion is an established therapy for stroke prevention in AF.
- Understanding its risks and benefits is crucial for patient and physician decision-making.
- The therapy expands options for primary and secondary stroke prevention.
Related Concept Videos
01:25Dysrhythmias VI: Management of Dysrhythmias
545
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
545
01:26Mitral Stenosis III: Medical Management
365
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
365
01:29Cardiomyopathy V: Interprofessional Care
542
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
542
01:25Aortic Regurgitation III: Medical Management
518
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
518
01:23Atherosclerosis IV: Nursing Management
531
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
531
01:28Acute Coronary Syndrome IV: Interprofessional Care
347
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
347